Stay updated with breaking news from Davidw Meline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $1.82, but opened at $1.78. Pacific Biosciences of California shares last traded at $1.84, with a volume of 2,907,306 shares changing hands. Wall Street Analysts Forecast Growth Several research analysts have […]
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fifteen research firms that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective lowered by Morgan Stanley from $10.00 to $4.00 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock. A number of other analysts have also recently weighed in on […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price decreased by Morgan Stanley from $10.00 to $4.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock. PACB has been the subject of a number of other […]
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) were up 10.1% on Monday . The company traded as high as $2.03 and last traded at $2.02. Approximately 5,116,811 shares traded hands during mid-day trading, a decline of 48% from the average daily volume of 9,845,091 shares. The stock had previously closed […]